chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 31.0
Sex: M
Vaccine: COVID19
Symptoms: Feeling hot, Pruritus
Clinical narrative: Client  received the COVID vaccine (Pfizer dose 1, lot # EW0187, expiration date 7/12/2021) in his left deltoid at 1835. The client reported to RN at 1705 that he was experiencing itching. RN  informed EMT and RN , who responded at that time. The client stated that the itching had started "5 minutes" after he was vaccinated and he was experiencing itching on his bilateral upper and lower extremities, as well as the back of his head. The client denied any shortness of breath or chest pain. The client didn't have any observable swelling on his head or tongue, and he had no observable rashes on his extremities or head. The client stated he had a history of hypertension but takes no medications, and he stated that he had an allergy to penicillin. The client stated that he last ate at noon. At 1710, the client's vital signs were as follows: blood pressure 158/112, heart rate 76, respiratory rate 18, O2 97%. The client stated he did not know his usual blood pressure range. The client denied any headache and his pulses were normal. The client stated that he was feeling "heat"; the client's skin was pink, warm, and dry. The client continued to denied any difficulty breathing. The client was alert and oriented x4. The client was offered water and oral Benadryl (50 mg) at 1710, which he accepted. At 1720, the client's vital signs were as follows: blood pressure 152/102, heart rate 74, O2 96%. The client stated that the itching had stayed the same. Education provided to the client and his partner regarding emergency management, primary care follow up, and v-safe. At 1730, the client's vital signs were as follows: blood pressure 150/96, heart rate 78, O2 95%. At 1735, the client stated that his symptoms of itching and heat had resolved. The client was sitting in his chair comfortably resting. At 1740, the client was able to stand without dizziness, and ambulated with a steady gait out to his car, where his partner drove him home.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Tinnitus
Clinical narrative: Ringing in left ear.  Ongoing and high pitched for 3-4 straight days
Age: 42.0
Sex: F
Vaccine: COVID19, UNK
Symptoms: Cardiac arrest, Death, Dyspnoea
Clinical narrative: Experienced shortness of breathe resulting in death cardiac arrest.
Age: 42.0
Sex: F
Vaccine: COVID19, UNK
Symptoms: Death, Dyspnoea, Pulse absent, Resuscitation, Syncope
Clinical narrative: Experienced shortness of breathe resulting in death cardiac arrest.
Age: 82.0
Sex: M
Vaccine: COVID19
Symptoms: Cerebrovascular accident
Clinical narrative: ACUTE STROKE 4 DAYS AFTER VACCINATION
Age: 30.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Cardiac flutter, Fatigue, Pyrexia
Clinical narrative: After first 5 minutes after initial shot, legs started tingling. Then nothing after that. By 7:00pm after initial shot, fatigue set in, and then I fell asleep. No notable events until Second Shot. Day of second second shot, around 7:00 PM, fever/fatigue set in. Next day feeling fine. Today's date: 6/24/2021 at the time of writing this, heart feels abnormal, but not alarmingly abnormal. There is a flutter of a heartbeat occasionally.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain, Blood glucose increased, Blood loss anaemia, Colonoscopy, Computerised tomogram abdomen abnormal
Clinical narrative: Pt was admitted from 4/7-4/8 for c/o bloody diarrhea and nausea for 1 week associated with fevers. Her hgb remained stable and she was discharged to follow up with GI on 4/8 with diarrhea resoled. CT scan at that time showed no acute abnl and minor sigmoid diverticulosis. She returned  on 6/9 with 4 days of bloody stool.  she was discharged on 6/16/21 after a protracted hospital course . Patient is a 67-year-old female with a past medical history significant for wheelchair-bound status secondary to MS and multiple left lower extremity surgeries, type 2 diabetes, CHF, hypertension, hyperlipidemia, depression, GERD who presented to the emergency room on 6/9/2021 for evaluation of bright red blood per rectum x4 days.  She was recently admitted in April for a day and a half for diarrhea that was bloody but symptoms resolved.  In the ER she was tachycardic and hypotensive she also had lactic acidosis.  She was ultimately admitted for anemia of acute blood loss, symptomatic hypotension and lower GI bleed as well as SIRS without sepsis.  She was seen in consultation by Gastroenterology and ultimately underwent a colonoscopy on 6/11/2021 which revealed no source for the bleeding and there was no evidence of malignancy she did have diverticulosis seen.  She had red-tinged stool throughout the ascending transverse descending and sigmoid colon as well as red bloody stool in the rectum.  She was on no blood thinners prior to arrival it stated in her med rec that she was on aspirin but she was not taking aspirin.  She remained in the hospital for close monitoring she did receive 2 units of blood.  We were hoping to advance her diet and plan discharge home but unfortunately patient began bleeding again and underwent a second colonoscopy on 6/14/2021 which again revealed the same bloody stool in the transverse, descending, sigmoid and rectum.  Patient did have a tagged bleeding scan which revealed evidence of bleeding with the tracer becoming visible in the region of the splenic flexure of the colon passing proximally and distally within the lumen of the colon.  Despite the second colonoscopy the bleeding source could not be found.  Patient was given an additional unit of blood.  She was monitored further.  She had a period of time after the colonoscopy where she had severe generalized abdominal pain but this resolved by the following day where she then began to have diarrhea but no further hematochezia or bleeding was noted. she was discharged on 6/16/21 home.   Of note this is the patient's fourth ER visit and or hospitalization since receiving her COVID-19 vaccinations.   CT showing no acute abnl and again diverticulosis. She received her 1st moderna covid 19 vaccine on 3/9  and her second on 4/9/21. she has had 2 hospitalizations since her vaccinations and 2 er visits 3/13 at another er noting increased blood sugars, blurred vision and a headache since her covid vaccine on 3/9 and 3/18 for fatigue, high blood sugars
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Diarrhoea haemorrhagic, Diverticulum, Gastrointestinal haemorrhage, Haemoglobin normal
Clinical narrative: Pt was admitted from 4/7-4/8 for c/o bloody diarrhea and nausea for 1 week associated with fevers. Her hgb remained stable and she was discharged to follow up with GI on 4/8 with diarrhea resoled. CT scan at that time showed no acute abnl and minor sigmoid diverticulosis. She returned  on 6/9 with 4 days of bloody stool.  she was discharged on 6/16/21 after a protracted hospital course . Patient is a 67-year-old female with a past medical history significant for wheelchair-bound status secondary to MS and multiple left lower extremity surgeries, type 2 diabetes, CHF, hypertension, hyperlipidemia, depression, GERD who presented to the emergency room on 6/9/2021 for evaluation of bright red blood per rectum x4 days.  She was recently admitted in April for a day and a half for diarrhea that was bloody but symptoms resolved.  In the ER she was tachycardic and hypotensive she also had lactic acidosis.  She was ultimately admitted for anemia of acute blood loss, symptomatic hypotension and lower GI bleed as well as SIRS without sepsis.  She was seen in consultation by Gastroenterology and ultimately underwent a colonoscopy on 6/11/2021 which revealed no source for the bleeding and there was no evidence of malignancy she did have diverticulosis seen.  She had red-tinged stool throughout the ascending transverse descending and sigmoid colon as well as red bloody stool in the rectum.  She was on no blood thinners prior to arrival it stated in her med rec that she was on aspirin but she was not taking aspirin.  She remained in the hospital for close monitoring she did receive 2 units of blood.  We were hoping to advance her diet and plan discharge home but unfortunately patient began bleeding again and underwent a second colonoscopy on 6/14/2021 which again revealed the same bloody stool in the transverse, descending, sigmoid and rectum.  Patient did have a tagged bleeding scan which revealed evidence of bleeding with the tracer becoming visible in the region of the splenic flexure of the colon passing proximally and distally within the lumen of the colon.  Despite the second colonoscopy the bleeding source could not be found.  Patient was given an additional unit of blood.  She was monitored further.  She had a period of time after the colonoscopy where she had severe generalized abdominal pain but this resolved by the following day where she then began to have diarrhea but no further hematochezia or bleeding was noted. she was discharged on 6/16/21 home.   Of note this is the patient's fourth ER visit and or hospitalization since receiving her COVID-19 vaccinations.   CT showing no acute abnl and again diverticulosis. She received her 1st moderna covid 19 vaccine on 3/9  and her second on 4/9/21. she has had 2 hospitalizations since her vaccinations and 2 er visits 3/13 at another er noting increased blood sugars, blurred vision and a headache since her covid vaccine on 3/9 and 3/18 for fatigue, high blood sugars
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Hypotension, Lactic acidosis, Nausea, Pyrexia, Rectal haemorrhage
Clinical narrative: Pt was admitted from 4/7-4/8 for c/o bloody diarrhea and nausea for 1 week associated with fevers. Her hgb remained stable and she was discharged to follow up with GI on 4/8 with diarrhea resoled. CT scan at that time showed no acute abnl and minor sigmoid diverticulosis. She returned  on 6/9 with 4 days of bloody stool.  she was discharged on 6/16/21 after a protracted hospital course . Patient is a 67-year-old female with a past medical history significant for wheelchair-bound status secondary to MS and multiple left lower extremity surgeries, type 2 diabetes, CHF, hypertension, hyperlipidemia, depression, GERD who presented to the emergency room on 6/9/2021 for evaluation of bright red blood per rectum x4 days.  She was recently admitted in April for a day and a half for diarrhea that was bloody but symptoms resolved.  In the ER she was tachycardic and hypotensive she also had lactic acidosis.  She was ultimately admitted for anemia of acute blood loss, symptomatic hypotension and lower GI bleed as well as SIRS without sepsis.  She was seen in consultation by Gastroenterology and ultimately underwent a colonoscopy on 6/11/2021 which revealed no source for the bleeding and there was no evidence of malignancy she did have diverticulosis seen.  She had red-tinged stool throughout the ascending transverse descending and sigmoid colon as well as red bloody stool in the rectum.  She was on no blood thinners prior to arrival it stated in her med rec that she was on aspirin but she was not taking aspirin.  She remained in the hospital for close monitoring she did receive 2 units of blood.  We were hoping to advance her diet and plan discharge home but unfortunately patient began bleeding again and underwent a second colonoscopy on 6/14/2021 which again revealed the same bloody stool in the transverse, descending, sigmoid and rectum.  Patient did have a tagged bleeding scan which revealed evidence of bleeding with the tracer becoming visible in the region of the splenic flexure of the colon passing proximally and distally within the lumen of the colon.  Despite the second colonoscopy the bleeding source could not be found.  Patient was given an additional unit of blood.  She was monitored further.  She had a period of time after the colonoscopy where she had severe generalized abdominal pain but this resolved by the following day where she then began to have diarrhea but no further hematochezia or bleeding was noted. she was discharged on 6/16/21 home.   Of note this is the patient's fourth ER visit and or hospitalization since receiving her COVID-19 vaccinations.   CT showing no acute abnl and again diverticulosis. She received her 1st moderna covid 19 vaccine on 3/9  and her second on 4/9/21. she has had 2 hospitalizations since her vaccinations and 2 er visits 3/13 at another er noting increased blood sugars, blurred vision and a headache since her covid vaccine on 3/9 and 3/18 for fatigue, high blood sugars
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Systemic inflammatory response syndrome, Tachycardia
Clinical narrative: Pt was admitted from 4/7-4/8 for c/o bloody diarrhea and nausea for 1 week associated with fevers. Her hgb remained stable and she was discharged to follow up with GI on 4/8 with diarrhea resoled. CT scan at that time showed no acute abnl and minor sigmoid diverticulosis. She returned  on 6/9 with 4 days of bloody stool.  she was discharged on 6/16/21 after a protracted hospital course . Patient is a 67-year-old female with a past medical history significant for wheelchair-bound status secondary to MS and multiple left lower extremity surgeries, type 2 diabetes, CHF, hypertension, hyperlipidemia, depression, GERD who presented to the emergency room on 6/9/2021 for evaluation of bright red blood per rectum x4 days.  She was recently admitted in April for a day and a half for diarrhea that was bloody but symptoms resolved.  In the ER she was tachycardic and hypotensive she also had lactic acidosis.  She was ultimately admitted for anemia of acute blood loss, symptomatic hypotension and lower GI bleed as well as SIRS without sepsis.  She was seen in consultation by Gastroenterology and ultimately underwent a colonoscopy on 6/11/2021 which revealed no source for the bleeding and there was no evidence of malignancy she did have diverticulosis seen.  She had red-tinged stool throughout the ascending transverse descending and sigmoid colon as well as red bloody stool in the rectum.  She was on no blood thinners prior to arrival it stated in her med rec that she was on aspirin but she was not taking aspirin.  She remained in the hospital for close monitoring she did receive 2 units of blood.  We were hoping to advance her diet and plan discharge home but unfortunately patient began bleeding again and underwent a second colonoscopy on 6/14/2021 which again revealed the same bloody stool in the transverse, descending, sigmoid and rectum.  Patient did have a tagged bleeding scan which revealed evidence of bleeding with the tracer becoming visible in the region of the splenic flexure of the colon passing proximally and distally within the lumen of the colon.  Despite the second colonoscopy the bleeding source could not be found.  Patient was given an additional unit of blood.  She was monitored further.  She had a period of time after the colonoscopy where she had severe generalized abdominal pain but this resolved by the following day where she then began to have diarrhea but no further hematochezia or bleeding was noted. she was discharged on 6/16/21 home.   Of note this is the patient's fourth ER visit and or hospitalization since receiving her COVID-19 vaccinations.   CT showing no acute abnl and again diverticulosis. She received her 1st moderna covid 19 vaccine on 3/9  and her second on 4/9/21. she has had 2 hospitalizations since her vaccinations and 2 er visits 3/13 at another er noting increased blood sugars, blurred vision and a headache since her covid vaccine on 3/9 and 3/18 for fatigue, high blood sugars
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: Blood urine present, Dysuria, Fatigue, Nephrolithiasis, Urine flow decreased
Clinical narrative: Kidney stones, 2 total, first the day after 2nd vaccination, 2nd the following day. Stones were moderate, blocking urine flow for about 30 minutes but passing with pain and very heavy bright blood. Self-treated with high fluid intake, blood dissipated reasonably. No recurrence. Also had a more usual and expected 2nd dose fatigue for several days.  Kidney stone history - passed a tiny tiny stone some 5 years before, with brief sting and trace blood; microscopic analysis by my doctor confirmed trace stones; scan indicated no significant problem. Reduced my tea intake.
Age: 37.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chest discomfort, Nausea
Clinical narrative: Client  received the 1st dose of Pfizer COVID vaccine (lot # ER8735 and expiration date 7/04/21) at approximately 2:48pm.  PHN  was doing a medical consult for a family member and noticed client touching mask and looking uncomfortable at 2:49pm.  Client reports feeling nauseous and having had chest pressure for a few seconds that had already resolved. PHN  request PHN to get emesis bag to provide to client. Client reports no blurred vision, no headache, no dizziness, no shortness of breath and no chest pain or pressure at this time. PHN offered client water and instructed to drink small amount, which client started to drink.  PHN  assist with vitals at 2:51pm: blood pressure:122/90, oxygen saturation:98%, and pulse:102. Client reports this has never happened before. PHN  assess for swelling in mouth and lips-none observed. At 2:56pm RN stepped in to assist PHN, vitals are blood pressure:120/84, pulse:94, and oxygen saturation: 99%.  Client reports no headache, no dizziness, no chest pain, no blurred vision, and decreased nausea.  At 3:01pm, vitals are blood pressure: 122/86, pulse: 82, and oxygen saturation: 97%. Client reports no headache, no blurred vision, no chest pain, no chest pressure, no dizziness, no shortness of breath, and nausea decreasing.  At 3:06pm, client reports that nausea has completely resolved.  At 3:10pm, vitals are blood pressure:122/80, oxygen saturation: 100%. and pulse:72.  Client reports no symptoms.  At 3:20pm vitals are blood pressure:124/80, oxygen saturation:98%, and  pulse:77. Client reports no symptoms. PHN  ask client if she has someone to drive for her and client responds "I feel fine to drive."  Provided client with ER precautions and to follow up with provider.  At 3:21pm client left facility with a steady gait.
Age: 37.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chest discomfort, Immediate post-injection reaction, Nausea
Clinical narrative: Client  received the 1st dose of Pfizer COVID vaccine (lot # ER8735 and expiration date 7/04/21) at approximately 2:48pm.  PHN  was doing a medical consult for a family member and noticed client touching mask and looking uncomfortable at 2:49pm.  Client reports feeling nauseous and having had chest pressure for a few seconds that had already resolved. PHN  request PHN to get emesis bag to provide to client. Client reports no blurred vision, no headache, no dizziness, no shortness of breath and no chest pain or pressure at this time. PHN offered client water and instructed to drink small amount, which client started to drink.  PHN  assist with vitals at 2:51pm: blood pressure:122/90, oxygen saturation:98%, and pulse:102. Client reports this has never happened before. PHN  assess for swelling in mouth and lips-none observed. At 2:56pm RN stepped in to assist PHN, vitals are blood pressure:120/84, pulse:94, and oxygen saturation: 99%.  Client reports no headache, no dizziness, no chest pain, no blurred vision, and decreased nausea.  At 3:01pm, vitals are blood pressure: 122/86, pulse: 82, and oxygen saturation: 97%. Client reports no headache, no blurred vision, no chest pain, no chest pressure, no dizziness, no shortness of breath, and nausea decreasing.  At 3:06pm, client reports that nausea has completely resolved.  At 3:10pm, vitals are blood pressure:122/80, oxygen saturation: 100%. and pulse:72.  Client reports no symptoms.  At 3:20pm vitals are blood pressure:124/80, oxygen saturation:98%, and  pulse:77. Client reports no symptoms. PHN  ask client if she has someone to drive for her and client responds "I feel fine to drive."  Provided client with ER precautions and to follow up with provider.  At 3:21pm client left facility with a steady gait.
Age: 19.0
Sex: M
Vaccine: COVID19
Symptoms: Chest pain, Palpitations
Clinical narrative: heart palpitation  and worsening chest pain started on 2nd day after vaccination
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Chest discomfort, Fatigue, Hypoaesthesia
Clinical narrative: NUMBNESS FROM BOTH ARMS SITE TO FINGERS. FATIGUE FOR 2 DAYS CHEST TIGHTNESS
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Disturbance in attention, Feeling abnormal, Headache, Injection site pain, Injection site reaction
Clinical narrative: headache for over 7 days on and off Injection site soreness (unable to lift or sleep on arm) for 3 days muscle spasms at injection site for 2 hours, around 8 hours after injection Brain fog on going, over 8+weeks past injection, unable to focus and concentrate. noticeable by family and co workers
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Loss of personal independence in daily activities, Muscle spasms, Sleep disorder
Clinical narrative: headache for over 7 days on and off Injection site soreness (unable to lift or sleep on arm) for 3 days muscle spasms at injection site for 2 hours, around 8 hours after injection Brain fog on going, over 8+weeks past injection, unable to focus and concentrate. noticeable by family and co workers
Age: 22.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Condition aggravated, Dysstasia, Fatigue, Feeling hot
Clinical narrative: Within 24 hours of booster dose of Moderna vaccine, noted severe joint pains which lasted about a day, and then worsening of profound, debilitating fatigue, worsening POTS, autonomic dysfunction symptoms--rapid heart rate, inability to stand for more than a few seconds, inability to walk longer than a few steps, temperature dysregulation (feeling too hot, night sweats); felt like a relapse of ME/CFS and POTS similar to the worsening of symptoms that occurred with mono infection--mostly bed bound, housebound. Still have not recovered to baseline before the vaccine.
Age: 22.0
Sex: F
Vaccine: COVID19
Symptoms: Gait disturbance, Heart rate increased, Loss of personal independence in daily activities, Night sweats, Post viral fatigue syndrome
Clinical narrative: Within 24 hours of booster dose of Moderna vaccine, noted severe joint pains which lasted about a day, and then worsening of profound, debilitating fatigue, worsening POTS, autonomic dysfunction symptoms--rapid heart rate, inability to stand for more than a few seconds, inability to walk longer than a few steps, temperature dysregulation (feeling too hot, night sweats); felt like a relapse of ME/CFS and POTS similar to the worsening of symptoms that occurred with mono infection--mostly bed bound, housebound. Still have not recovered to baseline before the vaccine.
Age: 22.0
Sex: F
Vaccine: COVID19
Symptoms: Postural orthostatic tachycardia syndrome
Clinical narrative: Within 24 hours of booster dose of Moderna vaccine, noted severe joint pains which lasted about a day, and then worsening of profound, debilitating fatigue, worsening POTS, autonomic dysfunction symptoms--rapid heart rate, inability to stand for more than a few seconds, inability to walk longer than a few steps, temperature dysregulation (feeling too hot, night sweats); felt like a relapse of ME/CFS and POTS similar to the worsening of symptoms that occurred with mono infection--mostly bed bound, housebound. Still have not recovered to baseline before the vaccine.
Age: 22.0
Sex: M
Vaccine: COVID19
Symptoms: Chest pain
Clinical narrative: Pain in chest around the heart area when exhaling.
Age: 17.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, C-reactive protein increased, Pain in extremity, Pruritus, Pyrexia
Clinical narrative: Rash & Fever - went to ED. + burning &  itching on back. Joint pain in fingers, joint pain rt elbow and wrist. Pain soles of feet. Started one week prior to 5/31/21. Dx'd with macular rash. Elevated C-reactive protein. Elevated sed. rate. Arthraligia of both hands. (Date of visit 5/31/21)
Age: 17.0
Sex: F
Vaccine: COVID19
Symptoms: Rash, Rash macular, Skin burning sensation
Clinical narrative: Rash & Fever - went to ED. + burning &  itching on back. Joint pain in fingers, joint pain rt elbow and wrist. Pain soles of feet. Started one week prior to 5/31/21. Dx'd with macular rash. Elevated C-reactive protein. Elevated sed. rate. Arthraligia of both hands. (Date of visit 5/31/21)
Age: 31.0
Sex: F
Vaccine: HEP
Symptoms: Hypoaesthesia, Limb discomfort
Clinical narrative: Right arm feels heavy/numb
Age: 0.33
Sex: M
Vaccine: DTAPHEPBIP, HEP, PNC13
Symptoms: Extra dose administered, Wrong product administered
Clinical narrative: Baby was inadvertently given 2 Hep B vaccines and was supposed to recieve a Hib vaccine and wasn't given the Hib, was given an extra dose of Hep B by mistake.
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Herpes zoster, Limb discomfort, Rash, Rash maculo-papular, Rash vesicular
Clinical narrative: 3-3-2021 "Chest rash - 4 to 5 days ago, pt with sense of sunburn in her left axilla, radiated down her left arm. On Monday , pt noticed two ~ 2cm maculopapular rashes on her left breast with a  small 0.5cm punctate lesion at mid sternum." Covid vaccine was 2 wks prior. - "Rash progressed across her back, with more vescular lesions." "I suspect that her first COVID immunization precipitated her shingles..."
Age: 0.33
Sex: M
Vaccine: DTAP, HIBV, IPV, PNC13
Symptoms: Injection site erythema, Injection site mass, Injection site swelling
Clinical narrative: Mother reported local reaction on the right thigh, redness and swelling from Dtap and Prevnar 13 injections. Mother also stated that the  lump is about two inches long, swollen, looks like a moskito bite. Advised mother to apply ice pack , HC cream 1 % TID & Tylenol 2.5 ml 4 hrs Prn.
Age: 91.0
Sex: U
Vaccine: COVID19
Symptoms: Acute myocardial infarction, Echocardiogram abnormal, Ejection fraction decreased, Electrocardiogram abnormal, Troponin increased
Clinical narrative: Acute MI
Age: 11.0
Sex: M
Vaccine: HPV9, MNQ, TDAP
Symptoms: Pallor, Vomiting
Clinical narrative: Patient became pale and vomited after vaccine administration.
Sex: M
Vaccine: UNK
Symptoms: Asthenia, Atrial fibrillation, Cardiac failure, Echocardiogram, Electrocardiogram
Clinical narrative: Patient felt tired with fast heart beating and general weakness; he went to bed and the symptoms accelerated overnight presenting to ER the following morning with severe heart failure and atrial fibrillation with rapid ventricle response.
Sex: M
Vaccine: UNK
Symptoms: Fatigue, Heart rate increased, Laboratory test
Clinical narrative: Patient felt tired with fast heart beating and general weakness; he went to bed and the symptoms accelerated overnight presenting to ER the following morning with severe heart failure and atrial fibrillation with rapid ventricle response.
Age: 60.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Computerised tomogram head normal, Differential white blood cell count normal, Dizziness, Formication, Full blood count normal
Clinical narrative: About a week or so after my second shot I started getting what I thought were tension headaches and  feelings of a crawling sensation at the top and sides of my head, as well as pressure over my eye with on-and-off dizziness. I went to my primary care MD who ordered CBC+Diff and a compete metabolic panel and CT scan. All came back normal. She referred me to neurologist who gave me methylPrednisolone  4 mg dose pack. No change. I then went to an ENT and had my ears checked for pressure and wax and hearing, all back fine. She gave me Rx for Flonase. I have been taking over-the-counter Excedrin Migraine, have gone to chiropractor as well as massage therapis. So far no relief.
Age: 60.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Metabolic function test normal, Ocular discomfort, Tension headache
Clinical narrative: About a week or so after my second shot I started getting what I thought were tension headaches and  feelings of a crawling sensation at the top and sides of my head, as well as pressure over my eye with on-and-off dizziness. I went to my primary care MD who ordered CBC+Diff and a compete metabolic panel and CT scan. All came back normal. She referred me to neurologist who gave me methylPrednisolone  4 mg dose pack. No change. I then went to an ENT and had my ears checked for pressure and wax and hearing, all back fine. She gave me Rx for Flonase. I have been taking over-the-counter Excedrin Migraine, have gone to chiropractor as well as massage therapis. So far no relief.
Age: 51.0
Sex: M
Vaccine: COVID19
Symptoms: Cardiac disorder, Eye pain, Insomnia, Lacrimation increased, Pain
Clinical narrative: PAIN (Can't even think, the pain is unbearable), INSOMNIA (Can't even sleep/hurts to lay down), EYE PAIN (Constant pain in his eye sockets), RHINORRHOEA (His nose is running/sinuses are being attacked) and SINUSITIS (sinuses are being attacked)  There is constant sinus pressure with teary eyes and especially intensified in certain positions.  I also am experiencing dental and heart problems. I am including a recent head X-ray with showing sinus clouding above my teeth.  Please help me resolve the issue as my second vaccination is still outstanding and doctors visits and expenses continue. Again, doctor visits are as recent as yesterday.  I would like to ask you for financial assistance for my expenses and additionally a head and heart MRI/Scan.
Age: 51.0
Sex: M
Vaccine: COVID19
Symptoms: Paranasal sinus discomfort, Rhinorrhoea, Sinus disorder, Sinusitis, Skull X-ray abnormal
Clinical narrative: PAIN (Can't even think, the pain is unbearable), INSOMNIA (Can't even sleep/hurts to lay down), EYE PAIN (Constant pain in his eye sockets), RHINORRHOEA (His nose is running/sinuses are being attacked) and SINUSITIS (sinuses are being attacked)  There is constant sinus pressure with teary eyes and especially intensified in certain positions.  I also am experiencing dental and heart problems. I am including a recent head X-ray with showing sinus clouding above my teeth.  Please help me resolve the issue as my second vaccination is still outstanding and doctors visits and expenses continue. Again, doctor visits are as recent as yesterday.  I would like to ask you for financial assistance for my expenses and additionally a head and heart MRI/Scan.
Age: 51.0
Sex: M
Vaccine: COVID19
Symptoms: Tooth disorder
Clinical narrative: PAIN (Can't even think, the pain is unbearable), INSOMNIA (Can't even sleep/hurts to lay down), EYE PAIN (Constant pain in his eye sockets), RHINORRHOEA (His nose is running/sinuses are being attacked) and SINUSITIS (sinuses are being attacked)  There is constant sinus pressure with teary eyes and especially intensified in certain positions.  I also am experiencing dental and heart problems. I am including a recent head X-ray with showing sinus clouding above my teeth.  Please help me resolve the issue as my second vaccination is still outstanding and doctors visits and expenses continue. Again, doctor visits are as recent as yesterday.  I would like to ask you for financial assistance for my expenses and additionally a head and heart MRI/Scan.
Age: 38.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Alanine aminotransferase normal, Albumin globulin ratio normal, Anti-thyroid antibody positive, Antinuclear antibody negative, Arthralgia
Clinical narrative: started to having arthralgias; myalgias; fever; fatigue; weakness; This is a spontaneous report from a contactable pharmacist. A 38-years-old female patient received first dose of bnt162b2 (Pfizer-Biontech COVID-19 Vaccine, Solution for injection, Batch/Lot Number: EH9899), via intramuscular route of administration on 18Dec2020 17:45 (at the age of 38-years-old)  in left arm as single dose for COVID-19 immunisation. Vaccination facilitated in hospital. The patient's medical history included high serum parathyroid hormone and low back pain. Patient had Known allergies: Darvocet-N. Concomitant medication were bupropion 75mg, tizanidine 2mg, Eluryng (ethinylestradiol, etonogestrel), Azelastine 137 mcg/inh (0.1%) nasal spray, fexofenadine 180 mg, and Flonase (fluticasone propionate) 50 mcg/inh nasal spray. No other vaccine was received in four weeks. The patient received second dose of bnt162b2 (Pfizer-Biontech COVID-19 Vaccine, Solution for injection, Batch/Lot Number: EL0142), via intramuscular route of administration on 12Jan2021 17:00 in left arm as single dose for COVID-19 immunisation. It was reported patient experienced arthralgia, myalgia, fever, fatigue and weakness starting on 20Dec2021. The patient continuously had arthralgias, myalgias and weakness for the next few weeks. She follow up with physical therapist once a week to work on muscle weakness. She continuously had arthralgias and myalgias until 10Jan2021. Primary care provider on 07Jan2021 orders CBC, autoimmune and thyroid panel since she was having ongoing myalgias and arthralgias. Patient postpone 2nd dose because side effects from 1st vaccine were ongoing. Patient got 2nd dose vaccine on 12Jan at 4:30pm. On 13Jan at 11am the patient initially had nausea and arthralgias. Patient took Zofran 4mg ODT about 11:15am. 30mins later the patient tongue swelled. No lips swelling and no SOB. Patient immediately took liquid Benadryl 50mg to 75mg PO (Oral). Patient presented to ED, observed until 2pm. Patient received treatment. Patient received treatment included 60mg prednisone x 1 dose in ED, prescription for prednisone 40mg x 3 days, Benadryl 25mg to 50mg ev. Patient visited doctor or other healthcare professional office/clinic visit, Emergency room/department or urgent care. No covid prior vaccination and No covid tested post vaccination. Neither prior vaccination nor post vaccination covid was tested. The outcome of the events started to having arthralgias, myalgias, on 10Jan2021 was recovered and for other events recovered on unspecified date on 2021.  Follow-up attempts are completed. No further information is expected.
Age: 38.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Aspartate aminotransferase normal, Basophil count normal, Basophil percentage, Blood albumin normal, Blood alkaline phosphatase normal
Clinical narrative: started to having arthralgias; myalgias; fever; fatigue; weakness; This is a spontaneous report from a contactable pharmacist. A 38-years-old female patient received first dose of bnt162b2 (Pfizer-Biontech COVID-19 Vaccine, Solution for injection, Batch/Lot Number: EH9899), via intramuscular route of administration on 18Dec2020 17:45 (at the age of 38-years-old)  in left arm as single dose for COVID-19 immunisation. Vaccination facilitated in hospital. The patient's medical history included high serum parathyroid hormone and low back pain. Patient had Known allergies: Darvocet-N. Concomitant medication were bupropion 75mg, tizanidine 2mg, Eluryng (ethinylestradiol, etonogestrel), Azelastine 137 mcg/inh (0.1%) nasal spray, fexofenadine 180 mg, and Flonase (fluticasone propionate) 50 mcg/inh nasal spray. No other vaccine was received in four weeks. The patient received second dose of bnt162b2 (Pfizer-Biontech COVID-19 Vaccine, Solution for injection, Batch/Lot Number: EL0142), via intramuscular route of administration on 12Jan2021 17:00 in left arm as single dose for COVID-19 immunisation. It was reported patient experienced arthralgia, myalgia, fever, fatigue and weakness starting on 20Dec2021. The patient continuously had arthralgias, myalgias and weakness for the next few weeks. She follow up with physical therapist once a week to work on muscle weakness. She continuously had arthralgias and myalgias until 10Jan2021. Primary care provider on 07Jan2021 orders CBC, autoimmune and thyroid panel since she was having ongoing myalgias and arthralgias. Patient postpone 2nd dose because side effects from 1st vaccine were ongoing. Patient got 2nd dose vaccine on 12Jan at 4:30pm. On 13Jan at 11am the patient initially had nausea and arthralgias. Patient took Zofran 4mg ODT about 11:15am. 30mins later the patient tongue swelled. No lips swelling and no SOB. Patient immediately took liquid Benadryl 50mg to 75mg PO (Oral). Patient presented to ED, observed until 2pm. Patient received treatment. Patient received treatment included 60mg prednisone x 1 dose in ED, prescription for prednisone 40mg x 3 days, Benadryl 25mg to 50mg ev. Patient visited doctor or other healthcare professional office/clinic visit, Emergency room/department or urgent care. No covid prior vaccination and No covid tested post vaccination. Neither prior vaccination nor post vaccination covid was tested. The outcome of the events started to having arthralgias, myalgias, on 10Jan2021 was recovered and for other events recovered on unspecified date on 2021.  Follow-up attempts are completed. No further information is expected.
Age: 38.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Blood bilirubin normal, Blood calcium normal, Blood chloride normal, Blood creatine phosphokinase normal, Blood creatinine normal
Clinical narrative: started to having arthralgias; myalgias; fever; fatigue; weakness; This is a spontaneous report from a contactable pharmacist. A 38-years-old female patient received first dose of bnt162b2 (Pfizer-Biontech COVID-19 Vaccine, Solution for injection, Batch/Lot Number: EH9899), via intramuscular route of administration on 18Dec2020 17:45 (at the age of 38-years-old)  in left arm as single dose for COVID-19 immunisation. Vaccination facilitated in hospital. The patient's medical history included high serum parathyroid hormone and low back pain. Patient had Known allergies: Darvocet-N. Concomitant medication were bupropion 75mg, tizanidine 2mg, Eluryng (ethinylestradiol, etonogestrel), Azelastine 137 mcg/inh (0.1%) nasal spray, fexofenadine 180 mg, and Flonase (fluticasone propionate) 50 mcg/inh nasal spray. No other vaccine was received in four weeks. The patient received second dose of bnt162b2 (Pfizer-Biontech COVID-19 Vaccine, Solution for injection, Batch/Lot Number: EL0142), via intramuscular route of administration on 12Jan2021 17:00 in left arm as single dose for COVID-19 immunisation. It was reported patient experienced arthralgia, myalgia, fever, fatigue and weakness starting on 20Dec2021. The patient continuously had arthralgias, myalgias and weakness for the next few weeks. She follow up with physical therapist once a week to work on muscle weakness. She continuously had arthralgias and myalgias until 10Jan2021. Primary care provider on 07Jan2021 orders CBC, autoimmune and thyroid panel since she was having ongoing myalgias and arthralgias. Patient postpone 2nd dose because side effects from 1st vaccine were ongoing. Patient got 2nd dose vaccine on 12Jan at 4:30pm. On 13Jan at 11am the patient initially had nausea and arthralgias. Patient took Zofran 4mg ODT about 11:15am. 30mins later the patient tongue swelled. No lips swelling and no SOB. Patient immediately took liquid Benadryl 50mg to 75mg PO (Oral). Patient presented to ED, observed until 2pm. Patient received treatment. Patient received treatment included 60mg prednisone x 1 dose in ED, prescription for prednisone 40mg x 3 days, Benadryl 25mg to 50mg ev. Patient visited doctor or other healthcare professional office/clinic visit, Emergency room/department or urgent care. No covid prior vaccination and No covid tested post vaccination. Neither prior vaccination nor post vaccination covid was tested. The outcome of the events started to having arthralgias, myalgias, on 10Jan2021 was recovered and for other events recovered on unspecified date on 2021.  Follow-up attempts are completed. No further information is expected.
Age: 38.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Blood folate abnormal, Blood glucose normal, Blood potassium normal, Blood sodium normal, Blood thyroid stimulating hormone decreased
Clinical narrative: started to having arthralgias; myalgias; fever; fatigue; weakness; This is a spontaneous report from a contactable pharmacist. A 38-years-old female patient received first dose of bnt162b2 (Pfizer-Biontech COVID-19 Vaccine, Solution for injection, Batch/Lot Number: EH9899), via intramuscular route of administration on 18Dec2020 17:45 (at the age of 38-years-old)  in left arm as single dose for COVID-19 immunisation. Vaccination facilitated in hospital. The patient's medical history included high serum parathyroid hormone and low back pain. Patient had Known allergies: Darvocet-N. Concomitant medication were bupropion 75mg, tizanidine 2mg, Eluryng (ethinylestradiol, etonogestrel), Azelastine 137 mcg/inh (0.1%) nasal spray, fexofenadine 180 mg, and Flonase (fluticasone propionate) 50 mcg/inh nasal spray. No other vaccine was received in four weeks. The patient received second dose of bnt162b2 (Pfizer-Biontech COVID-19 Vaccine, Solution for injection, Batch/Lot Number: EL0142), via intramuscular route of administration on 12Jan2021 17:00 in left arm as single dose for COVID-19 immunisation. It was reported patient experienced arthralgia, myalgia, fever, fatigue and weakness starting on 20Dec2021. The patient continuously had arthralgias, myalgias and weakness for the next few weeks. She follow up with physical therapist once a week to work on muscle weakness. She continuously had arthralgias and myalgias until 10Jan2021. Primary care provider on 07Jan2021 orders CBC, autoimmune and thyroid panel since she was having ongoing myalgias and arthralgias. Patient postpone 2nd dose because side effects from 1st vaccine were ongoing. Patient got 2nd dose vaccine on 12Jan at 4:30pm. On 13Jan at 11am the patient initially had nausea and arthralgias. Patient took Zofran 4mg ODT about 11:15am. 30mins later the patient tongue swelled. No lips swelling and no SOB. Patient immediately took liquid Benadryl 50mg to 75mg PO (Oral). Patient presented to ED, observed until 2pm. Patient received treatment. Patient received treatment included 60mg prednisone x 1 dose in ED, prescription for prednisone 40mg x 3 days, Benadryl 25mg to 50mg ev. Patient visited doctor or other healthcare professional office/clinic visit, Emergency room/department or urgent care. No covid prior vaccination and No covid tested post vaccination. Neither prior vaccination nor post vaccination covid was tested. The outcome of the events started to having arthralgias, myalgias, on 10Jan2021 was recovered and for other events recovered on unspecified date on 2021.  Follow-up attempts are completed. No further information is expected.
Age: 38.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Blood urea normal, C-reactive protein normal, Carbon dioxide decreased, Eosinophil count decreased, Eosinophil percentage decreased
Clinical narrative: started to having arthralgias; myalgias; fever; fatigue; weakness; This is a spontaneous report from a contactable pharmacist. A 38-years-old female patient received first dose of bnt162b2 (Pfizer-Biontech COVID-19 Vaccine, Solution for injection, Batch/Lot Number: EH9899), via intramuscular route of administration on 18Dec2020 17:45 (at the age of 38-years-old)  in left arm as single dose for COVID-19 immunisation. Vaccination facilitated in hospital. The patient's medical history included high serum parathyroid hormone and low back pain. Patient had Known allergies: Darvocet-N. Concomitant medication were bupropion 75mg, tizanidine 2mg, Eluryng (ethinylestradiol, etonogestrel), Azelastine 137 mcg/inh (0.1%) nasal spray, fexofenadine 180 mg, and Flonase (fluticasone propionate) 50 mcg/inh nasal spray. No other vaccine was received in four weeks. The patient received second dose of bnt162b2 (Pfizer-Biontech COVID-19 Vaccine, Solution for injection, Batch/Lot Number: EL0142), via intramuscular route of administration on 12Jan2021 17:00 in left arm as single dose for COVID-19 immunisation. It was reported patient experienced arthralgia, myalgia, fever, fatigue and weakness starting on 20Dec2021. The patient continuously had arthralgias, myalgias and weakness for the next few weeks. She follow up with physical therapist once a week to work on muscle weakness. She continuously had arthralgias and myalgias until 10Jan2021. Primary care provider on 07Jan2021 orders CBC, autoimmune and thyroid panel since she was having ongoing myalgias and arthralgias. Patient postpone 2nd dose because side effects from 1st vaccine were ongoing. Patient got 2nd dose vaccine on 12Jan at 4:30pm. On 13Jan at 11am the patient initially had nausea and arthralgias. Patient took Zofran 4mg ODT about 11:15am. 30mins later the patient tongue swelled. No lips swelling and no SOB. Patient immediately took liquid Benadryl 50mg to 75mg PO (Oral). Patient presented to ED, observed until 2pm. Patient received treatment. Patient received treatment included 60mg prednisone x 1 dose in ED, prescription for prednisone 40mg x 3 days, Benadryl 25mg to 50mg ev. Patient visited doctor or other healthcare professional office/clinic visit, Emergency room/department or urgent care. No covid prior vaccination and No covid tested post vaccination. Neither prior vaccination nor post vaccination covid was tested. The outcome of the events started to having arthralgias, myalgias, on 10Jan2021 was recovered and for other events recovered on unspecified date on 2021.  Follow-up attempts are completed. No further information is expected.
Age: 38.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Globulin, Glomerular filtration rate decreased, Glycosylated haemoglobin normal, Haematocrit normal, Haemoglobin normal
Clinical narrative: started to having arthralgias; myalgias; fever; fatigue; weakness; This is a spontaneous report from a contactable pharmacist. A 38-years-old female patient received first dose of bnt162b2 (Pfizer-Biontech COVID-19 Vaccine, Solution for injection, Batch/Lot Number: EH9899), via intramuscular route of administration on 18Dec2020 17:45 (at the age of 38-years-old)  in left arm as single dose for COVID-19 immunisation. Vaccination facilitated in hospital. The patient's medical history included high serum parathyroid hormone and low back pain. Patient had Known allergies: Darvocet-N. Concomitant medication were bupropion 75mg, tizanidine 2mg, Eluryng (ethinylestradiol, etonogestrel), Azelastine 137 mcg/inh (0.1%) nasal spray, fexofenadine 180 mg, and Flonase (fluticasone propionate) 50 mcg/inh nasal spray. No other vaccine was received in four weeks. The patient received second dose of bnt162b2 (Pfizer-Biontech COVID-19 Vaccine, Solution for injection, Batch/Lot Number: EL0142), via intramuscular route of administration on 12Jan2021 17:00 in left arm as single dose for COVID-19 immunisation. It was reported patient experienced arthralgia, myalgia, fever, fatigue and weakness starting on 20Dec2021. The patient continuously had arthralgias, myalgias and weakness for the next few weeks. She follow up with physical therapist once a week to work on muscle weakness. She continuously had arthralgias and myalgias until 10Jan2021. Primary care provider on 07Jan2021 orders CBC, autoimmune and thyroid panel since she was having ongoing myalgias and arthralgias. Patient postpone 2nd dose because side effects from 1st vaccine were ongoing. Patient got 2nd dose vaccine on 12Jan at 4:30pm. On 13Jan at 11am the patient initially had nausea and arthralgias. Patient took Zofran 4mg ODT about 11:15am. 30mins later the patient tongue swelled. No lips swelling and no SOB. Patient immediately took liquid Benadryl 50mg to 75mg PO (Oral). Patient presented to ED, observed until 2pm. Patient received treatment. Patient received treatment included 60mg prednisone x 1 dose in ED, prescription for prednisone 40mg x 3 days, Benadryl 25mg to 50mg ev. Patient visited doctor or other healthcare professional office/clinic visit, Emergency room/department or urgent care. No covid prior vaccination and No covid tested post vaccination. Neither prior vaccination nor post vaccination covid was tested. The outcome of the events started to having arthralgias, myalgias, on 10Jan2021 was recovered and for other events recovered on unspecified date on 2021.  Follow-up attempts are completed. No further information is expected.